Home : Company : Q News : Quantimetrix Corporation Releases GlycoHemosure, Its New Hemoglobin A1c Control

Quantimetrix Corporation Releases GlycoHemosure, Its New Hemoglobin A1c Control

August 7, 2003

Redondo Beach, CA – August 7, 2003 – Quantimetrix Corporation is offering a new serum hemoglobin A1c control, GlycoHemosure.

The Quantimetrix GlycoHemosure, HbA1c control is intended as a reference material for the monitoring of Serum hemoglobin A1c. Hemoglobin A1c is an important analyte for the long term assessment of glucose levels in diabetic patients.

This product is supplied as a ready use liquid requiring no reconstitution and is prepared from human serum.

Quantimetrix provides a comparative quality control program called Quantrol™ which is available for its products. Free monthly reports are provided for participants allowing each lab to monitor test performance and trend analysis.

Quantimetrix develops and manufactures innovative clinical diagnostic products for global distribution, including Lipoprint®, the only diagnostic test for the separation and measurement of cholesterol in lipoprotein fractions and subfractions. Other products include urinalysis, general and specialty chemistry controls, electrophoresis systems, diagnostic assays and OEM controls. Quantimetrix corporate headquarters is located at 2005 Manhattan Beach Blvd., Redondo Beach, CA 90278; phone: 800-624-8380. Additional information about the company and its products can be found at www.4qc.com.